Ebola vaccine induces T cell cross-reactivity against Bundibugyo virus in humans

1 week ago 8
The existent Bundibugyo Ebola microorganism (BDBV) outbreak successful the Democratic Republic of the Congo is the 2nd largest Ebola outbreak worldwide, with implicit 6,000 confirmed cases and a 48% fatality rate. There is presently nary approved BDBV vaccine.
Read Entire Article